High-Fiber Plant-Based Diet May Delay Multiple Myeloma Progression
Can a Plant-Based Diet Delay Multiple Myeloma? Promising Study Suggests It Might
New York, NY – A groundbreaking study from Memorial sloan Kettering Cancer Center (MSK) offers a glimmer of hope for individuals at risk of developing multiple myeloma, a rare and incurable blood cancer. The research, presented at the 2024 American Society of Hematology (ASH) annual meeting in San Diego, California, suggests that a high-fiber, plant-based diet may significantly delay the progression of this devastating disease.The study,led by MSK myeloma specialist Dr. urvi Shah, involved 20 participants diagnosed with a precancerous blood disorder and an elevated body mass index (BMI), placing them at increased risk for multiple myeloma. Over a 36-week period, participants adhered to a structured high-fiber, plant-based meal plan, receiving ongoing dietary coaching.
the results were encouraging. two participants who had shown signs of advancing disease prior to the trial experienced a remarkable improvement in their disease progression trajectory. Furthermore, at the one-year mark, none of the participants had progressed to multiple myeloma.
“This study showcases the power of nutrition—specifically a high fiber plant-based diet—and unlocks a better understanding of how it can led to improvements in the microbiome and metabolism to build a stronger immune system,” said Dr. Shah. “These findings further support how we as physicians can empower patients, especially those with precancerous conditions, with knowledge on reducing their cancer risk through dietary changes.”
Multiple myeloma, the second most common blood cancer, typically develops from precursor conditions like monoclonal gammopathy of undetermined importance (MGUS) and smoldering (symptomless) myeloma.While this study offers promising early results, further research is needed to confirm these findings and explore the long-term impact of a high-fiber, plant-based diet on multiple myeloma progression.
Plant-Based Diet Shows Promise in Preventing multiple Myeloma Progression
New research suggests a whole-food, plant-based diet may help slow or even prevent the progression of smoldering multiple myeloma, a precursor to the blood cancer.
The study, presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, focused on the impact of diet on individuals with smoldering multiple myeloma, a condition where abnormal plasma cells are present in the bone marrow but haven’t yet caused significant damage.
“We certainly know that individuals with poor diet quality and reduced plant food intake have an increased risk of multiple myeloma,” said Dr. Supriya Shah, lead researcher and hematologist-oncologist at Memorial Sloan Kettering Cancer Center. “Our findings suggest that dietary interventions may play a crucial role in preventing this progression.”
The study involved participants adopting a whole-food, plant-based diet rich in fruits, vegetables, nuts, seeds, whole grains, and legumes. Remarkably, participants experienced significant improvements in quality of life, insulin resistance, gut microbiome health, and inflammation. On average, they lost eight percent of their body weight after just 12 weeks.
These promising results were further supported by a smoldering myeloma mouse model. Mice fed a high-fiber diet showed a 44% reduction in progression to myeloma compared to mice on a standard diet, where all mice developed the disease.
Encouraged by these findings, Dr. Shah is currently leading a larger, multi-center study called NUTRIVENTION-3, which will enroll 150 participants to further investigate the impact of a plant-based diet on smoldering multiple myeloma.
this research offers a glimmer of hope for individuals at risk of developing multiple myeloma, suggesting that dietary changes may be a powerful tool in preventing disease progression.
Can Going Green Delay Multiple Myeloma? A Conversation wiht Dr. Urvi Shah
New York, NY – A recent study from Memorial Sloan Kettering Cancer Center (MSK) has sparked a wave of interest in the potential of dietary intervention to delay the onset of multiple myeloma, a rare adn incurable blood cancer. We spoke with Dr. Urvi Shah, the lead author of this groundbreaking research, to shed light on the findings and implications.
NewsDirectory3: Dr. Shah, can you tell us more about the study and its key findings?
Dr. Shah: We enrolled 20 participants who were diagnosed with a precancerous blood disorder and had an elevated BMI, putting them at increased risk for multiple myeloma. These participants followed a structured high-fiber,plant-based diet for 36 weeks,with ongoing dietary coaching from our team.
The results were quite promising. Two participants who had shown signs of progressing towards multiple myeloma prior to the trial experienced a remarkable improvement in their disease trajectory. Also, at the one-year mark, none of the participants had developed multiple myeloma.
NewsDirectory3: These are indeed encouraging findings. What mechanisms might be at play?
Dr. Shah: while further research is necessary to fully understand the mechanisms involved, we believe that the high-fiber content of the plant-based diet might potentially be playing a crucial role. Fiber is known to promote a healthy gut microbiome, which has been linked to improved immune function and reduced inflammation. Both factors are believed to play a role in the development and progression of multiple myeloma.
NewsDirectory3: How significant are these findings in the context of current multiple myeloma treatment and prevention strategies?
Dr. Shah: This is still early-stage research, but the findings are certainly intriguing.
Currently, there is no guaranteed way to prevent multiple myeloma.
Our study suggests that a dietary intervention, specifically a high-fiber, plant-based diet, could potentially delay its onset in individuals at risk. This offers a significant potential benefit, allowing for earlier intervention and potentially improved outcomes.
NewsDirectory3: What are the next steps for your research?
Dr. Shah: We are currently conducting larger-scale clinical trials to confirm our initial findings and further investigate the underlying mechanisms.We are also exploring the potential benefits of this dietary approach in people already diagnosed with multiple myeloma.
NewsDirectory3: Thank you for sharing your insights, Dr. Shah. Your research offers a beacon of hope for those at risk of developing this devastating disease.
Disclaimer: This facts is for educational purposes only and should not be considered medical advice. It is indeed crucial to consult with a qualified healthcare professional for any questions or concerns about your health or treatment options.